Gregory A. Ratti

Intensive Care Medicine

5939 Harry Hines Blvd
Dallas, TX 75235

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Pulmonary response to glucagon-like peptide-1 receptor agonist therapy in adults with cystic fibrosis-related diabetes: factors associated with improvement in FEV1.

Pulmonary response to glucagon-like peptide-1 receptor agonist therapy in adults with cystic fibrosis-related diabetes: factors associated with improvement in FEV1.

Journal: Respiratory medicine

Published: May 30, 2026

Changes in metabolic and pulmonary outcomes after discontinuation of glucagon-like-peptide-1 receptor agonist therapy in people with cystic fibrosis.

Changes in metabolic and pulmonary outcomes after discontinuation of glucagon-like-peptide-1 receptor agonist therapy in people with cystic fibrosis.

Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society

Published: February 20, 2026

Impact of glucagon-like-peptide-1 receptor agonist therapy on pulmonary function in people with cystic fibrosis who achieve normal body mass index.

Impact of glucagon-like-peptide-1 receptor agonist therapy on pulmonary function in people with cystic fibrosis who achieve normal body mass index.

Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society

Published: August 11, 2025

Management Patterns and Outcomes of Invasive Mechanical Ventilation in Patients With Cardiogenic Shock.

Management Patterns and Outcomes of Invasive Mechanical Ventilation in Patients With Cardiogenic Shock.

Journal: JACC. Advances

Published: February 27, 2025

Long-Term Clinical Efficacy of Elexacaftor-Tezacaftor-Ivacaftor in People With Cystic Fibrosis and Preexisting Advanced Lung Disease at Treatment Initiation.

Long-Term Clinical Efficacy of Elexacaftor-Tezacaftor-Ivacaftor in People With Cystic Fibrosis and Preexisting Advanced Lung Disease at Treatment Initiation.

Journal: CHEST pulmonary

Published: September 07, 2024

Reduced levels of liver kinase B1 in small extracellular vesicles as a predictor for chronic lung allograft dysfunction in cystic fibrosis lung transplant recipients.

Reduced levels of liver kinase B1 in small extracellular vesicles as a predictor for chronic lung allograft dysfunction in cystic fibrosis lung transplant recipients.

Journal: Human immunology

Published: June 06, 2024

Development of metabolic syndrome in people with Cystic Fibrosis one year after exposure to elexacaftor-tezacaftor-ivacaftor.

Development of metabolic syndrome in people with Cystic Fibrosis one year after exposure to elexacaftor-tezacaftor-ivacaftor.

Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society

Published: January 08, 2024

Catheterization Without Supination-A Series of 36 Prone Position Internal Jugular Vein Cannulations.

Catheterization Without Supination-A Series of 36 Prone Position Internal Jugular Vein Cannulations.

Journal: Critical care explorations

Published: January 05, 2023

Evaluation of an association between RANKL and OPG with bone disease in people with cystic fibrosis.

Evaluation of an association between RANKL and OPG with bone disease in people with cystic fibrosis.

Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society

Published: February 14, 2022

Bone mineral density screening by DXA for people with cystic fibrosis: A registry analysis of patient and program factors influencing rates of screening.

Bone mineral density screening by DXA for people with cystic fibrosis: A registry analysis of patient and program factors influencing rates of screening.

Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society

Published: September 24, 2021

Showing 1-10 of 10

Last Updated: 09/26/2026